0000899243-20-017080.txt : 20200618
0000899243-20-017080.hdr.sgml : 20200618
20200618163037
ACCESSION NUMBER: 0000899243-20-017080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200617
FILED AS OF DATE: 20200618
DATE AS OF CHANGE: 20200618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bailey Jeffrey Allen
CENTRAL INDEX KEY: 0001500210
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 20972955
MAIL ADDRESS:
STREET 1: KING PHARMACEUTICALS, INC.
STREET 2: 501 FIFTH STREET
CITY: BRISTOL
STATE: TN
ZIP: 37620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-17
0
0001420565
AILERON THERAPEUTICS INC
ALRN
0001500210
Bailey Jeffrey Allen
C/O AILERON THERAPEUTICS, INC.
490 ARSENAL WAY
WATERTOWN
MA
02472
1
0
0
0
Stock Option (right to buy)
1.15
2020-06-17
4
A
0
12500
0.00
A
2030-06-16
Common Stock
12500
12500
D
This option was granted on June 17, 2020. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 17, 2021 or (ii) the date of the Issuer's 2021 Annual Meeting of Stockholders.
/s/ Richard Wanstall, attorney-in-fact for Jeffrey Allen Bailey
2020-06-18